- Title
- Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019 : a systematic analysis for the Global Burden of Disease Study 2019
- Creator
- Shin, Youn; Hwang, Jimin; Kwon, Rosie; Lee, Seeung; Kim, Min; Shin, Jae; Yon, Dong; Abate, Yohannes; Abbasi-Kangevari, Mohsen; Abbasi-Kangevari, Zeinab; Abdelmasseh, Michael; Abdulah, Deldar; Aboagye, Richard; Abolhassani, Hassan; Abrams, Elissa; Abtew, Yonas; Abu-Gharbieh, Eman; Adane Adane, Denberu; Adane, Tigist; Addo, Isaac; Adha, Rishan; Adibi, Amin; Sakilah Adnani, Qorinah; Agrawal, Anurag; Ahmad, Sohail; Ahmadi, Ali; Ahmed, Ali; Ahmed, Ayman; Alif, Sheikh; Rahman, Muhammad Aziz
- Date
- 2023
- Type
- Text; Journal article
- Identifier
- http://researchonline.federation.edu.au/vital/access/HandleResolver/1959.17/199661
- Identifier
- vital:19262
- Identifier
-
https://doi.org/10.1111/all.15807
- Identifier
- ISSN:0105-4538 (ISSN)
- Abstract
- Background: Asthma and atopic dermatitis (AD) are chronic allergic conditions, along with allergic rhinitis and food allergy and cause high morbidity and mortality both in children and adults. This study aims to evaluate the global, regional, national, and temporal trends of the burden of asthma and AD from 1990 to 2019 and analyze their associations with geographic, demographic, social, and clinical factors. Methods: Using data from the Global Burden of Diseases (GBD), Injuries, and Risk Factors Study 2019, we assessed the age-standardized prevalence, incidence, mortality, and disability-adjusted life years (DALYs) of both asthma and AD from 1990 to 2019, stratified by geographic region, age, sex, and socio-demographic index (SDI). DALYs were calculated as the sum of years lived with disability and years of life lost to premature mortality. Additionally, the disease burden of asthma attributable to high body mass index, occupational asthmagens, and smoking was described. Results: In 2019, there were a total of 262 million [95% uncertainty interval (UI): 224–309 million] cases of asthma and 171 million [95% UI: 165–178 million] total cases of AD globally; age-standardized prevalence rates were 3416 [95% UI: 2899–4066] and 2277 [95% UI: 2192–2369] per 100,000 population for asthma and AD, respectively, a 24.1% [95% UI:
- Publisher
- John Wiley and Sons Inc
- Relation
- Allergy: European Journal of Allergy and Clinical Immunology Vol. 78, no. 8 (2023), p. 2232-2254
- Rights
- All metadata describing materials held in, or linked to, the repository is freely available under a CC0 licence
- Rights
- Copyright © 2023 EAACI and John Wiley and Sons A/S
- Rights
- Open Access
- Subject
- 3204 Immunology; Asthma; Atopic dermatitis; Disability-adjusted life years; Eczema; Epidemiology; Global burden; Mortality
- Full Text
- Reviewed
- Funder
- This study was funded by the Bill and Melinda Gates Foundation, Australian National Health and Medical Research Council, and Queensland Department of Health, Australia and National Research Foundation of Korea (NRF) grant funded by the Korea government (NRF- 2021R1I1A2059735 and RS-2023- 00248157). The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. All authors had full ac-cess to the study data and had final responsibility for the decision to submit for publication.
- Hits: 456
- Visitors: 448
- Downloads: 1
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details Download | SOURCE1 | Published version | 9 MB | Adobe Acrobat PDF | View Details Download |